TY  - JOUR
AU  - Fernandez-Ruiz, M.
AU  - Guinea, J.
AU  - Lora-Pablos, D.
AU  - Zaragoza, O.
AU  - Puig-Asensio, M.
AU  - Almirante, B.
AU  - Cuenca-Estrella, M.
AU  - Aguado, J. M.
AU  - CANDIPOP Project
AU  - GEIH-GEMICOMED SEIMC
AU  - REIPI
PY  - 2017
DO  - 10.1016/j.cmi.2017.01.014
SN  - 1198-743X
UR  - http://hdl.handle.net/10668/18753
T2  - Clinical microbiology and infection
AB  - Objectives: The clinical correlation of fluconazole antifungal susceptibility testing (AST) for Candida isolates and its integration with pharmacokinetics/pharmacodynamics (PK/PD) parameters is unclear. We analysed the impact of fluconazole minimum...
LA  - en
PB  - Elsevier sci ltd
KW  - Candidaemia
KW  - Fluconazole
KW  - Outcome
KW  - PK/PD parameters
KW  - Susceptibility
KW  - Critically-ill patients
KW  - Blood-stream infection
KW  - Propensity score analysis
KW  - Antifungal susceptibility
KW  - Dose/mic ratio
KW  - Interpretive breakpoints
KW  - Nonneutropenic patients
KW  - Therapeutic response
KW  - Diseases society
KW  - Candidemia
TI  - Impact of fluconazole susceptibility on the outcome of patients with candidaemia: data from a population-based surveillance
TY  - research article
VL  - 23
ER  -